Page results
-
This information is for children and young people with type 1 diabetes using a hybrid closed loop (HCL).
-
Volunteers are a highly valued part of the team at UCLH. Volunteering is a great way of giving back, doing something different and get some experience. Roles tend to be for a minimum of half a day a week for 6 months. For most of our roles you don’t necessarily need have to have prior experience as the key things we are looking for are great people skills and an ability to give us a regular commitment.
-
At UCLH, we encourage self-referral to our antenatal service, but you also have the choice to go via your GP who will make the referral for you.
-
This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia.
-
Care in the last days of life: information for families, friends and carers.
-
You can use MyCare on your mobile, tablet or computer to securely view and manage information about your health and care at UCLH.
-
The purpose of this page is to explain what an ectopic pregnancy is, what it means for your health, the different treatment options, risks involved in treatment, and potential risks in future pregnancies.
-
This information provides information for women who have chosen to have surgical management using local anaesthetic following their diagnosis of a miscarriage.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided Caudal Epidural injections to patients referred by the Camden community MSK services.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
File results
-
FOI/2024/0143 - Individuals arriving at A&E not in an ambulance
-
FOI/2024/0144 - Breast cancer treatment
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer
-
FOI/2024/0162 - Various technology systems/ services used at Trust
-
FOI/2024/0163 - Renal cell carcinoma and melanoma treatments
-
FOI/2024/0166 - Recruitment systems/CRM platform
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0172 - Patients excluded from care at the Trust 2010-2023